Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value ($000): $273,064 (100.0% shares, 0.0% debt)

Holdings (19)

REPL Replimune Group 27.1%

Value ($000) $74,056 Shares 4,288,154 Est. Cost $17.40 Unrealized +9.6%

— Imago Biosciences 16.6%

Value ($000) $45,432 Shares 3,018,737 Est. Cost $20.03 Unrealized —

NUVB Nuvation Bio 12.4%

Value ($000) $33,762 Shares 15,072,340 Est. Cost $11.18 Unrealized -74.5%

— Cincor Pharma 6.7%

Value ($000) $18,412 Shares 560,985 Est. Cost $17.54 Unrealized —

GOSS Gossamer Bio 6.6%

Value ($000) $17,970 Shares 1,500,000 Est. Cost $20.85 Unrealized -40.5%

— Morphic Holding 6.2%

Value ($000) $16,916 Shares 597,723 Est. Cost $19.82 Unrealized —

— Alpine Immune Sciences 5.4%

Value ($000) $14,613 Shares 2,029,580 Est. Cost $9.48 Unrealized —

— Kronos Bio 4.7%

Value ($000) $12,791 Shares 3,818,283 Est. Cost $29.87 Unrealized —

— Ikena Oncology 2.9%

Value ($000) $7,984 Shares 2,249,123 Est. Cost $28.25 Unrealized —

IMUX Immunic Inc 2.1%

Value ($000) $5,651 Shares 1,788,160 Est. Cost $13.89 Unrealized -69.9%

— Paratek Pharmaceuticals 1.9%

Value ($000) $5,066 Shares 1,971,241 Est. Cost $34.18 Unrealized —

SANA Sana Biotechnology, Inc. 1.9%

Value ($000) $5,063 Shares 843,750 Est. Cost $32.56 Unrealized -77.8%

— Omega Alpha SPAC 1.8%

Value ($000) $4,975 Shares 501,000 Est. Cost $9.98 Unrealized —

— Theseus Pharmaceuticals 1.5%

Value ($000) $4,127 Shares 711,479 Est. Cost $12.68 Unrealized —

— Spruce Biosciences 1.1%

Value ($000) $2,961 Shares 2,161,022 Est. Cost $24.31 Unrealized —

SYRS Syros Pharmaceuticals 0.6%

Value ($000) $1,618 Shares 251,270 Est. Cost $8.12 Unrealized 0.0%

— Jounce Therapeutics 0.2%

Value ($000) $645 Shares 275,513 Est. Cost $21.99 Unrealized —

— ESSA Pharma 0.2%

Value ($000) $597 Shares 328,196 Est. Cost $3.14 Unrealized —

— Senti Biosciences, Inc. 0.2%

Value ($000) $425 Shares 195,792 Est. Cost $1.97 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
REPL	Replimune Group	4,288,154	$74,056	27.1%	$17.40	+9.6%	Common Stock	76029N106
—	Imago Biosciences	3,018,737	$45,432	16.6%	$20.03	—	Common Stock	45250K107
NUVB	Nuvation Bio	15,072,340	$33,762	12.4%	$11.18	-74.5%	Common Stock Class A	67080N101
—	Cincor Pharma	560,985	$18,412	6.7%	$17.54	—	Common Stock	17240Y109
GOSS	Gossamer Bio	1,500,000	$17,970	6.6%	$20.85	-40.5%	Common Stock	38341P102
—	Morphic Holding	597,723	$16,916	6.2%	$19.82	—	Common Stock	61775R105
—	Alpine Immune Sciences	2,029,580	$14,613	5.4%	$9.48	—	Common Stock	02083G100
—	Kronos Bio	3,818,283	$12,791	4.7%	$29.87	—	Common Stock	50107A104
—	Ikena Oncology	2,249,123	$7,984	2.9%	$28.25	—	Common Stock	45175G108
IMUX	Immunic Inc	1,788,160	$5,651	2.1%	$13.89	-69.9%	Common Stock	4525EP101
—	Paratek Pharmaceuticals	1,971,241	$5,066	1.9%	$34.18	—	Common Stock	699374302
SANA	Sana Biotechnology, Inc.	843,750	$5,063	1.9%	$32.56	-77.8%	Common Stock	799566104
—	Omega Alpha SPAC	501,000	$4,975	1.8%	$9.98	—	Common Stock Class A	G6749V107
—	Theseus Pharmaceuticals	711,479	$4,127	1.5%	$12.68	—	Common Stock	88369M101
—	Spruce Biosciences	2,161,022	$2,961	1.1%	$24.31	—	Common Stock	85209E109
SYRS	Syros Pharmaceuticals	251,270	$1,618	0.6%	$8.12	0.0%	Common Stock	87184Q206
—	Jounce Therapeutics	275,513	$645	0.2%	$21.99	—	Common Stock	481116101
—	ESSA Pharma	328,196	$597	0.2%	$3.14	—	Common Stock	29668H708
—	Senti Biosciences, Inc.	195,792	$425	0.2%	$1.97	—	Common Stock	81726A100